Evidence map›Paper›PMID 33603164›Full record

ArticleOncogene2021

Cx43 phosphorylation sites regulate pancreatic cancer metastasis.

Joell L Solan, Sunil R Hingorani, Paul D Lampe

Open access · greenAbstract read
In one paragraph

Article in Oncogene, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Joell L SolanFrom the Translational Research Program, Public Health Sciences Division, Seattle, WA, 98109, USA.
Sunil R HingoraniFrom the Translational Research Program, Public Health Sciences Division, Seattle, WA, 98109, USA.
Paul D LampeFrom the Translational Research Program, Public Health Sciences Division, Seattle, WA, 98109, USA. plampe@fredhutch.org.ORCID http://orcid.org/0000-0002-1399-2761
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZAFred Hutch Cancer Center · US

Funding

PHOSPHORYLATION OF GAP JUNCTION PROTEINSR01GM055632 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI LAMPE, PAUL D. · 1997 to 2017
$6.1M
Investigating the metastatic drive in pancreas cancerR01CA223483 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI HINGORANI, SUNIL R · 2018 to 2022
$2.4M
Cx43 phosphorylation modulates Kras mediated pancreas cancer progressionR21CA149554 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI LAMPE, PAUL D. · 2010 to 2012
$415k
NCI NIH HHS R01 CA223483NCI NIH HHS R21 CA149554NIGMS NIH HHS R01 GM055632
6 · The paper itself

Abstract

Pancreatic ductal adenocarcinoma (PDA) is aggressive, highly metastatic and characterized by a robust desmoplasia. Connexin proteins that form gap junctions have been implicated in tumor suppression for over 30 years. Cx43, the most widely expressed connexin, regulates cell behaviors, including migration and proliferation. Thus, we hypothesized that Cx43 could regulate PDA progression. Phosphorylation of Cx43 by Casein Kinase 1 (CK1) regulates gap junction assembly. We interbred the well-established Kras

Indexed as

AdenocarcinomaAnimalsCarcinogenesisCarcinoma, Pancreatic DuctalCasein Kinase ICell ProliferationConnexin 43Gap JunctionsHumansInterferon-Stimulated Gene Factor 3, gamma SubunitMiceNeoplasm MetastasisPhosphorylationProto-Oncogene Proteins p21(ras)Casein Kinase IConnexin 43Hras protein, mouseInterferon-Stimulated Gene Factor 3, gamma SubunitIsgf3g protein, mouseProto-Oncogene Proteins p21(ras)

Identifiers

PMID33603164
PMCPMC8191514
OpenAlexW3132862163

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.